Stockreport

Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second tri-specific antibody, [Read more]